SunOpta Clears Court and Canadian Antitrust Hurdles for Refresco Takeover

What happened

SunOpta has obtained final approval from the Ontario Superior Court and a no-action letter under Canada's Competition Act for its $6.50 per share acquisition by Refresco. This follows the shareholder vote on April 16, 2026, which likely met the ≥66⅔% threshold as anticipated in the DeepValue report. The report highlighted these approvals as critical path items for a Q2 2026 close, with the stock at $6.48 offering minimal upside to the offer price. While these milestones reduce near-term uncertainty, significant regulatory risks remain, including U.S. HSR and Vietnam VCC approvals, which could delay or jeopardize the deal. Investors should remain cautious as the asymmetric risk profile persists, with downside to $4.50 if the deal breaks and limited upside at current prices.

Implication

With court and Canadian approvals secured, the probability of a Q2 2026 close increases, but investors must monitor U.S. and Vietnam antitrust processes for potential delays. The stock trading at $6.48 provides almost no spread to the $6.50 offer, making it unattractive for new positions without a discount to compensate for remaining risks. If U.S. or Vietnam regulators issue information requests, the timeline could extend beyond Q2, causing the price to drop towards the standalone value of around $4.50. The DeepValue report highlights SunOpta's leveraged balance sheet and operational volatility, which would exacerbate downside in a deal-break scenario. Therefore, prudent investors should await confirmation of all regulatory clearances or consider entry only below $6.25 to improve risk-reward.

Thesis delta

The news validates the base case scenario in the DeepValue report, confirming that court and Canadian antitrust hurdles are cleared as expected. However, the investment thesis remains largely unchanged: upside is capped at $6.50, and material downside risk persists from U.S. and Vietnam regulatory reviews and the dissenter cap. No significant shift in valuation or probability is warranted at this stage.